FDA Denies Imposition of More Regulations on Third-Party Servicers
The U.S. FDA has ruled that there is insufficient evidence to currently “justify imposing additional/different burdensome regulatory requirements” on third-party servicers of medical devices. The decision appeared in the agency’s report on the quality, safety, and effectiveness of medical device servicing—which was mandated as part of the FDA Reauthorization Act of 2017.
Read More